Trade NGNE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Neurogene Inc. (NGNE) is trading at US$31.85, down 0.75% today as of Sep 21, 14:44 EDT. The company has a market capitalisation of US$773.04M. Over the past 52 weeks, NGNE has traded between US$15.93 and US$43.66. On Syfe you can trade NGNE with $0 commission and add it to your watchlist.
| Previous close | US$32.09 |
|---|---|
| Market cap | US$773.04M |
| 52-week range | US$15.93 – US$43.66 |
| Volume | 1.39M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Neurogene Inc.
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Year: 2023
Neurogene Prices $125 Million Public Offering
Jul 1, 11:51 AM · MT Newswires
Neurogene Launches Public Offering
Jun 30, 8:25 PM · MT Newswires
Neurogene Says Phase 1/2 NGN-401 Data Show Progressive Improvements in Rett Syndrome
Jun 29, 11:57 AM · MT Newswires
Neurogene Completes Enrollment in Embolden Trial of NGN-401
Jun 8, 12:54 PM · MT Newswires
Neurogene Insider Sold Shares Worth $300,043, According to a Recent SEC Filing
May 8, 3:56 PM · MT Newswires
Neurogene Inc. (NGNE) stock is trading at US$31.85, -0.75% from the previous close of US$32.09.
The market cap for Neurogene Inc. (NGNE) stock is approximately US$773.04M.
The 52-week high for Neurogene Inc. (NGNE) stock is US$43.66.
The 52-week low for Neurogene Inc. (NGNE) stock is US$15.93.
Neurogene Inc. (NGNE) does not currently pay a dividend.
Stay on top of NGNE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
